Olanzapine for the treatment of borderline personality disorder: Variable dose 12-week randomised double-blind placebo-controlled study

  • S. Charles Schulz
  • , Mary C. Zanarini
  • , Anthony Bateman
  • , Martin Bohus
  • , Holland C. Detke
  • , Quynh Trzaskoma
  • , Yoko Tanaka
  • , Daniel Lin
  • , Walter Deberdt
  • , Sara Corya

Research output: Contribution to journal › Article › peer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Olanzapine for the treatment of borderline personality disorder: Variable dose 12-week randomised double-blind placebo-controlled study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience